DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury

Lior Molcho, Tali Ben-Zur, Yael Barhum, Daniel Offen

Research output: Contribution to journalArticlepeer-review

Abstract

Stroke is a leading cause of death worldwide and inflicts serious long-term damage and disability. The vasoconstrictor Endothelin-1, presenting long-term neurological deficits associated with excitotoxicity and oxidative stress is being increasingly used to induce focal ischemic injury as a model of stroke. A DJ-1 based peptide named ND-13 was shown to protect against glutamate toxicity, neurotoxic insults and oxidative stress in various animal models. Here we focus on the benefits of treatment with ND-13 on the functional outcome of focal ischemic injury. Wild type C57BL/6 mice treated with ND-13, after ischemic induction in this model, showed significant improvement in motor function, including improved body balance and motor coordination, and decreased motor asymmetry. We found that DJ-1 knockout mice are more sensitive to Endothelin-1 ischemic insult than wild type mice, contributing thereby additional evidence to the widely reported relevance of DJ-1 in neuroprotection. Furthermore, treatment of DJ-1 knockout mice with ND-13, following Endothelin-1 induced ischemia, resulted in significant improvement in motor functions, suggesting that ND-13 provides compensation for DJ-1 deficits. These preliminary results demonstrate a possible basis for clinical application of the ND-13 peptide to enhance neuroprotection in stroke patients.

Original languageEnglish
Article numbere0192954
JournalPLoS ONE
Volume13
Issue number2
DOIs
StatePublished - Feb 2018

Fingerprint

Dive into the research topics of 'DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury'. Together they form a unique fingerprint.

Cite this